KRT80 and breast carcinoma: YP et al. 14 found that SREBP1 could target the enhancer of KRT80 and upregulate the expression of KRT80, which could promote cytoskeletal rearrangements at the leading edge, increase focal adhesion and cellular stiffening, and promote the invasion of breast cancer cells.